Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Cook QS, Zdanski CJ, Burkhart CN, Googe PB, Thompson P, Wu EY.

Curr Allergy Asthma Rep. 2019 May 14;19(6):32. doi: 10.1007/s11882-019-0864-4. Review.

PMID:
31089823
2.

Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.

Weske S, Vaidya M, von Wnuck Lipinski K, Keul P, Manthe K, Burkhart C, Haberhauer G, Heusch G, Levkau B.

Bone. 2019 Aug;125:1-7. doi: 10.1016/j.bone.2019.04.015. Epub 2019 Apr 24.

PMID:
31028959
3.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11.

PMID:
30872156
4.

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Jul;81(1):91-101. doi: 10.1016/j.jaad.2019.02.068. Epub 2019 Mar 11.

PMID:
30872149
5.

Solitary plaque on the leg of a child: A report of two cases and a brief review of acral pseudolymphomatous angiokeratoma of children and unilesional mycosis fungoides.

Evans MS, Burkhart CN, Bowers EV, Culpepper KS, Googe PB, Magro CM.

Pediatr Dermatol. 2019 Jan;36(1):e1-e5. doi: 10.1111/pde.13686. Epub 2018 Oct 15. Review.

PMID:
30318629
6.

A Transfer Learning Approach for Microstructure Reconstruction and Structure-property Predictions.

Li X, Zhang Y, Zhao H, Burkhart C, Brinson LC, Chen W.

Sci Rep. 2018 Sep 7;8(1):13461. doi: 10.1038/s41598-018-31571-7.

7.

Germline-activating mutations in PIK3CD compromise B cell development and function.

Avery DT, Kane A, Nguyen T, Lau A, Nguyen A, Lenthall H, Payne K, Shi W, Brigden H, French E, Bier J, Hermes JR, Zahra D, Sewell WA, Butt D, Elliott M, Boztug K, Meyts I, Choo S, Hsu P, Wong M, Berglund LJ, Gray P, O'Sullivan M, Cole T, Holland SM, Ma CS, Burkhart C, Corcoran LM, Phan TG, Brink R, Uzel G, Deenick EK, Tangye SG.

J Exp Med. 2018 Aug 6;215(8):2073-2095. doi: 10.1084/jem.20180010. Epub 2018 Jul 17.

8.

A Multidisciplinary Consensus for Clinical Care and Research Needs for Sturge-Weber Syndrome.

De la Torre AJ, Luat AF, Juhász C, Ho ML, Argersinger DP, Cavuoto KM, Enriquez-Algeciras M, Tikkanen S, North P, Burkhart CN, Chugani HT, Ball KL, Pinto AL, Loeb JA.

Pediatr Neurol. 2018 Jul;84:11-20. doi: 10.1016/j.pediatrneurol.2018.04.005. Epub 2018 Apr 18. Review.

PMID:
29803545
9.

TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells.

Leonova K, Safina A, Nesher E, Sandlesh P, Pratt R, Burkhart C, Lipchick B, Gitlin I, Frangou C, Koman I, Wang J, Kirsanov K, Yakubovskaya MG, Gudkov AV, Gurova K.

Elife. 2018 Feb 5;7. pii: e30842. doi: 10.7554/eLife.30842.

10.

Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.

Rao VK, Webster S, Dalm VASH, Šedivá A, van Hagen PM, Holland S, Rosenzweig SD, Christ AD, Sloth B, Cabanski M, Joshi AD, de Buck S, Doucet J, Guerini D, Kalis C, Pylvaenaeinen I, Soldermann N, Kashyap A, Uzel G, Lenardo MJ, Patel DD, Lucas CL, Burkhart C.

Blood. 2017 Nov 23;130(21):2307-2316. doi: 10.1182/blood-2017-08-801191. Epub 2017 Sep 29.

11.

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors.

Hoegenauer K, Soldermann N, Zécri F, Strang RS, Graveleau N, Wolf RM, Cooke NG, Smith AB, Hollingworth GJ, Blanz J, Gutmann S, Rummel G, Littlewood-Evans A, Burkhart C.

ACS Med Chem Lett. 2017 Aug 25;8(9):975-980. doi: 10.1021/acsmedchemlett.7b00293. eCollection 2017 Sep 14.

12.

The Internet for patient education on atopic dermatitis: Friend or foe?

Corcimaru A, Morrell DS, Burkhart CN.

J Am Acad Dermatol. 2017 Jun;76(6):1197-1198. doi: 10.1016/j.jaad.2017.01.054. No abstract available.

PMID:
28522047
13.

Associations Between Impaired Cerebral Blood Flow Autoregulation, Cerebral Oxygenation, and Biomarkers of Brain Injury and Postoperative Cognitive Dysfunction in Elderly Patients After Major Noncardiac Surgery.

Goettel N, Burkhart CS, Rossi A, Cabella BC, Berres M, Monsch AU, Czosnyka M, Steiner LA.

Anesth Analg. 2017 Mar;124(3):934-942. doi: 10.1213/ANE.0000000000001803.

PMID:
28151820
14.

Mind the gap! Automated concept map feedback supports students in writing cohesive explanations.

Lachner A, Burkhart C, Nückles M.

J Exp Psychol Appl. 2017 Mar;23(1):29-46. doi: 10.1037/xap0000111. Epub 2017 Jan 2.

PMID:
28045279
15.

Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties.

Hoegenauer K, Soldermann N, Hebach C, Hollingworth GJ, Lewis I, von Matt A, Smith AB, Wolf RM, Wilcken R, Haasen D, Burkhart C, Zécri F.

Bioorg Med Chem Lett. 2016 Dec 1;26(23):5657-5662. doi: 10.1016/j.bmcl.2016.10.069. Epub 2016 Oct 27.

PMID:
27816514
16.

Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.

Kim M, Neznanov N, Wilfong CD, Fleyshman DI, Purmal AA, Haderski G, Stanhope-Baker P, Burkhart CA, Gurova KV, Gudkov AV, Skitzki JJ.

Cancer Res. 2016 Nov 15;76(22):6620-6630. doi: 10.1158/0008-5472.CAN-15-2764. Epub 2016 Sep 28.

17.

Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors.

Hoegenauer K, Soldermann N, Stauffer F, Furet P, Graveleau N, Smith AB, Hebach C, Hollingworth GJ, Lewis I, Gutmann S, Rummel G, Knapp M, Wolf RM, Blanz J, Feifel R, Burkhart C, Zécri F.

ACS Med Chem Lett. 2016 Jun 2;7(8):762-7. doi: 10.1021/acsmedchemlett.6b00119. eCollection 2016 Aug 11.

18.

Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.

Barone TA, Burkhart CA, Safina A, Haderski G, Gurova KV, Purmal AA, Gudkov AV, Plunkett RJ.

Neuro Oncol. 2017 Feb 1;19(2):186-196. doi: 10.1093/neuonc/now141.

19.

Predicting the occurrence of major adverse cardiac events within 30 days of a vascular surgery: an empirical comparison of the minimum p value method and ROC curve approach using individual patient data meta-analysis.

Vanniyasingam T, Rodseth RN, Lurati Buse GA, Bolliger D, Burkhart CS, Cuthbertson BH, Gibson SC, Mahla E, Leibowitz DW, Biccard BM, Thabane L.

Springerplus. 2016 Mar 9;5:304. doi: 10.1186/s40064-016-1936-8. eCollection 2016.

20.

Differentiation of latex allergy from irritant contact dermatitis.

Burkhart C, Schloemer J, Zirwas M.

Cutis. 2015 Dec;96(6):369-71, 401.

PMID:
26761937
21.

Planarized Intramolecular Charge Transfer: A Concept for Fluorophores with both Large Stokes Shifts and High Fluorescence Quantum Yields.

Haberhauer G, Gleiter R, Burkhart C.

Chemistry. 2016 Jan 18;22(3):971-8. doi: 10.1002/chem.201503927. Epub 2015 Dec 16.

PMID:
26670768
22.

Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.

Carter DR, Murray J, Cheung BB, Gamble L, Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, Issaeva N, Biktasova A, Atmadibrata B, Sun Y, Sokolowski N, Ling D, Kim PY, Webber H, Clark A, Ruhle M, Liu B, Oberthuer A, Fischer M, Byrne J, Saletta F, Thwe le M, Purmal A, Haderski G, Burkhart C, Speleman F, De Preter K, Beckers A, Ziegler DS, Liu T, Gurova KV, Gudkov AV, Norris MD, Haber M, Marshall GM.

Sci Transl Med. 2015 Nov 4;7(312):312ra176. doi: 10.1126/scitranslmed.aab1803.

23.

Microbiome and pediatric atopic dermatitis.

Powers CE, McShane DB, Gilligan PH, Burkhart CN, Morrell DS.

J Dermatol. 2015 Dec;42(12):1137-42. doi: 10.1111/1346-8138.13072. Epub 2015 Sep 21. Review.

PMID:
26388516
24.

Monitoring of cerebral blood flow autoregulation in adults undergoing sevoflurane anesthesia: a prospective cohort study of two age groups.

Goettel N, Patet C, Rossi A, Burkhart CS, Czosnyka M, Strebel SP, Steiner LA.

J Clin Monit Comput. 2016 Jun;30(3):255-64. doi: 10.1007/s10877-015-9754-z. Epub 2015 Aug 19.

PMID:
26285741
25.

Predictors of the variability in neuromuscular block duration following succinylcholine: A prospective, observational study.

Dell-Kuster S, Levano S, Burkhart CS, Lelais F, Zemp A, Schobinger E, Hampl K, Kindler C, Girard T.

Eur J Anaesthesiol. 2015 Oct;32(10):687-96. doi: 10.1097/EJA.0000000000000308.

PMID:
26213905
26.

Acne therapeutics: a closer look at benzoyl peroxide.

Mohammad TF, Burkhart CG.

Skinmed. 2015 Mar-Apr;13(2):94-6. No abstract available.

PMID:
26137733
27.

Is the current model for acne pathogenesis backwards?

Metiko B, Brooks K, Burkhart CG, Burkhart CN, Morrell D.

J Am Acad Dermatol. 2015 Jun;72(6):e167. doi: 10.1016/j.jaad.2015.01.041. No abstract available.

PMID:
25981026
28.

Adverse effects of acne medications: recognition and management.

Oudenhoven MD, Kinney MA, McShane DB, Burkhart CN, Morrell DS.

Am J Clin Dermatol. 2015 Aug;16(4):231-242. doi: 10.1007/s40257-015-0127-7. Review.

PMID:
25896771
29.

Pediatric periorificial dermatitis: clinical course and treatment outcomes in 222 patients.

Goel NS, Burkhart CN, Morrell DS.

Pediatr Dermatol. 2015 May-Jun;32(3):333-6. doi: 10.1111/pde.12534. Epub 2015 Apr 6.

PMID:
25847356
30.

Isotretinoin and vitiligo: can chronic cheilitis cause koebnerization?

Garner ML, McShane DB, Burkhart CN, Morrell DS.

Pediatr Dermatol. 2015 May-Jun;32(3):e108-9. doi: 10.1111/pde.12538. Epub 2015 Mar 17.

PMID:
25781892
31.

Wolf's Isotopic Response: Varicella Within a Prior Immunization Reaction Site.

Wu S, McShane DB, Burkhart CN, Morrell DS.

Pediatr Dermatol. 2015 May-Jun;32(3):e110-1. doi: 10.1111/pde.12536. Epub 2015 Mar 17.

PMID:
25779371
32.

Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.

Bornancin F, Renner F, Touil R, Sic H, Kolb Y, Touil-Allaoui I, Rush JS, Smith PA, Bigaud M, Junker-Walker U, Burkhart C, Dawson J, Niwa S, Katopodis A, Nuesslein-Hildesheim B, Weckbecker G, Zenke G, Kinzel B, Traggiai E, Brenner D, Brüstle A, St Paul M, Zamurovic N, McCoy KD, Rolink A, Régnier CH, Mak TW, Ohashi PS, Patel DD, Calzascia T.

J Immunol. 2015 Apr 15;194(8):3723-34. doi: 10.4049/jimmunol.1402254. Epub 2015 Mar 11.

33.

Light and chemically driven molecular machines showing a unidirectional four-state switching cycle.

Haberhauer G, Burkhart C, Woitschetzki S, Wölper C.

J Org Chem. 2015 Feb 6;80(3):1887-95. doi: 10.1021/acs.joc.5b00026. Epub 2015 Jan 26.

PMID:
25585273
34.

Thread epilation: a less traumatic technique for patients undergoing isotretinoin therapy.

Wu S, Bhandari R, Burkhart CN.

Pediatr Dermatol. 2015 Jan-Feb;32(1):158-9. doi: 10.1111/pde.12453. Epub 2014 Dec 29.

PMID:
25556964
35.

Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.

Burkhart C, Fleyshman D, Kohrn R, Commane M, Garrigan J, Kurbatov V, Toshkov I, Ramachandran R, Martello L, Gurova KV.

Oncotarget. 2014 Nov 30;5(22):11038-53.

36.

Genetics of hemangiomas, vascular malformations, and primary lymphedema.

Blatt J, Powell CM, Burkhart CN, Stavas J, Aylsworth AS.

J Pediatr Hematol Oncol. 2014 Nov;36(8):587-93. doi: 10.1097/MPH.0000000000000260. Review.

PMID:
25222064
37.

Liquid nitrogen under the microscope: review of recent rulings, discussion on various grades, and considerations in evaluating supplier source.

Burkhart CG, Burkhart CN.

Int J Dermatol. 2014 Dec;53(12):1539-41. doi: 10.1111/ijd.12618. Epub 2014 Sep 10. Review. No abstract available.

PMID:
25208733
38.

Serum anticholinergic activity and postoperative cognitive dysfunction in elderly patients.

Rossi A, Burkhart C, Dell-Kuster S, Pollock BG, Strebel SP, Monsch AU, Kern C, Steiner LA.

Anesth Analg. 2014 Oct;119(4):947-55. doi: 10.1213/ANE.0000000000000390.

PMID:
25089730
39.

Airborne contact dermatitis: common causes in the USA.

Schloemer JA, Zirwas MJ, Burkhart CG.

Int J Dermatol. 2015 Mar;54(3):271-4. doi: 10.1111/ijd.12692. Epub 2014 Jul 1. Review.

PMID:
24981079
40.

Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis-associated delirium in septic patients.

Burkhart CS, Dell-Kuster S, Siegemund M, Pargger H, Marsch S, Strebel SP, Steiner LA.

Acta Anaesthesiol Scand. 2014 Jul;58(6):689-700. doi: 10.1111/aas.12313. Epub 2014 Mar 24.

PMID:
24660837
41.

Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.

Moye V, Cathcart S, Burkhart CN, Morrell DS.

Dermatol Ther. 2013 Nov-Dec;26(6):445-51. doi: 10.1111/dth.12105. Review.

PMID:
24552407
42.

Multiscale modeling of polyisoprene on graphite.

Pandey YN, Brayton A, Burkhart C, Papakonstantopoulos GJ, Doxastakis M.

J Chem Phys. 2014 Feb 7;140(5):054908. doi: 10.1063/1.4863918.

PMID:
24511980
43.

High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.

Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS.

JAMA Dermatol. 2013 Dec;149(12):1392-8. doi: 10.1001/jamadermatol.2013.6746.

PMID:
24173086
44.

Sunscreen regulations and use of anti-inflammatory agents in sunscreens.

Haydar K, Burkhart CG.

Dermatol Online J. 2013 Jul 14;19(7):18969.

45.

Cell-based methods for the identification of MYC-inhibitory small molecules.

Burkhart CA, Haber M, Norris MD, Gudkov AV, Nikiforov MA.

Methods Mol Biol. 2013;1012:255-64. doi: 10.1007/978-1-62703-429-6_18.

46.

Efficient 3D porous microstructure reconstruction via Gaussian random field and hybrid optimization.

Jiang Z, Chen W, Burkhart C.

J Microsc. 2013 Nov;252(2):135-48. doi: 10.1111/jmi.12077. Epub 2013 Aug 20.

47.

Respect begins at home.

Burkhart CN, Morrell DS, Ziemer C.

J Am Acad Dermatol. 2013 Aug;69(2):315-6. doi: 10.1016/j.jaad.2013.05.001. No abstract available.

PMID:
23866869
48.

Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.

Collmann E, Bohnacker T, Marone R, Dawson J, Rehberg M, Stringer R, Krombach F, Burkhart C, Hirsch E, Hollingworth GJ, Thomas M, Wymann MP.

J Allergy Clin Immunol. 2013 Oct;132(4):959-68. doi: 10.1016/j.jaci.2013.03.008. Epub 2013 May 14.

PMID:
23683463
49.

Pasteurella multocida cellulitis in a 15-year-old male with chronic lymphedema.

Blasiak RC, Morrell DS, Burkhart CN.

J Am Acad Dermatol. 2013 Jun;68(6):e183-4. doi: 10.1016/j.jaad.2012.11.003. No abstract available.

PMID:
23680213
50.

A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations.

Blatt J, McLean TW, Castellino SM, Burkhart CN.

Pharmacol Ther. 2013 Sep;139(3):327-33. doi: 10.1016/j.pharmthera.2013.05.001. Epub 2013 May 8. Review.

PMID:
23665062

Supplemental Content

Loading ...
Support Center